Gastric and Gastroesophageal Junction Adenocarcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-01-25
Clinical Trial Update: Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma [Phase 1]
Phase 1 trial update for AMG 910 in CLDN18.2-positive gastric and gastroesophageal junction adenocarcinoma; study status terminated with res…